# XIFIN

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xifin

- Industry: Healthcare IT
- Headquarters: San Diego, US
- Website: www.xifin.com
- Total disclosed funding: $8.6M
- Latest round: Series D (Aug 22, 2006)
- Investors on record: 4

## About

XIFIN, Inc. is a US-based company specializing in revenue cycle management solutions for laboratories and diagnostic service providers, enhancing operational efficiency within the healthcare sector.Founded in 1997 in San Diego, US, XIFIN, Inc. focuses on providing innovative software solutions for laboratories and diagnostic services. The company has raised a total of USD 1.00 mn and completed 11 deals, with its latest funding round, Series D, occurring on July 23, 2021, supported by investors including Boulder Ventures and Enterprise Partners Venture Capital. Lale White currently serves as CEO, while Don LaVigne is one of the founders.XIFIN is a leading provider of revenue cycle management solutions specifically designed for laboratories and diagnostic service providers. Its core offerings include advanced software platforms that streamline billing, improve collections, and enhance overall operational efficiency within the healthcare sector. The company focuses on addressing critical pain points such as delays in payment processing and inefficient claims management, which are common challenges faced by diagnostic laboratories. XIFIN’s solutions cater to a diverse client base that includes independent labs, hospitals, and integrated healthcare systems in North America and select countries across Europe. The company emphasizes its commitment to enhancing the financial performance of its clients through its innovative technologies and services.XIFIN generates revenue predominantly through its subscription-based model, which provides clients with access to its proprietary software solutions. This transactional structure allows laboratories to leverage advanced billing and revenue management tools while paying a recurring fee for continuous service and support. Clients typically engage with XIFIN’s services through multi-year contracts that ensure a stable revenue stream for the company. The pricing plans are formulated based on the scale of operations and specific needs of each client, which may include tiered support levels and specialized features tailored to individual laboratory requirements. By focusing on high-value partnerships and a robust service model, XIFIN aims to drive sustainable growth and client satisfaction in the competitive healthcare landscape.XIFIN plans to utilize its recent funding from the Series D round to further develop its software offerings and enhance service capabilities. The company is also exploring expansion into new geographical markets, with targeted efforts in Europe and Canada aimed for completion by 2023. Additionally, XIFIN is in the process of designing new products to streamline billing processes even further, with expected launches in late 2022.

## Funding rounds

- Series D, Aug 22, 2006, $1M — Enterprise Partners Venture Capital, Boulder Ventures, Windward Ventures, RR Group Investments
- Series D, Jun 14, 2005, $0.8M — Enterprise Partners Venture Capital, Boulder Ventures
- Series D, Dec 1, 2004, $1M — Enterprise Partners Venture Capital, Boulder Ventures, Windward Ventures
- Series C, Jan 22, 2004, $2M — Enterprise Partners Venture Capital, Boulder Ventures, Windward Ventures
- Series B, Jan 21, 2003, $3.8M — Enterprise Partners Venture Capital

## Investors

- Enterprise Partners Venture Capital (https://capitalatlas.ai/funds/enterprise-partners-venture-capital) — Series B, Series C, Series D
- Boulder Ventures (https://capitalatlas.ai/funds/boulder-ventures) — Series C, Series D
- Windward Ventures (https://capitalatlas.ai/funds/windward-ventures) — Series C, Series D
- RR Group Investments — Series D